List of Contents

Pain Management Devices Market Size, Share, and Trends 2024 to 2034

The global pain management devices market size is calculated at USD 5.32 billion in 2024, grew to USD 5.82 billion in 2025 and is predicted to surpass around USD 13.06 billion by 2034, expanding at a CAGR of 9.40% between 2024 and 2034. The North America pain management devices market size accounted for USD 2.50 billion in 2024 and is anticipated to grow at a fastest CAGR of 9.50% during the forecast year.

  • Last Updated : October 2024
  • Report Code : 1469
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pain Management Devices Market 

5.1. COVID-19 Landscape: Pain Management Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pain Management Devices Market, By Product

8.1. Pain Management Devices Market, by Product Type, 2024-2034

8.1.1. Electrical Stimulation Devices (TENS, Others)

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Radiofrequency (RF) Ablation Devices

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Neuromodulation Devices

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Infusion Pumps (Intrathecal Infusion Pumps, External Infusion Pumps)

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Pain Management Devices Market, By Application

9.1. Pain Management Devices Market, by Application, 2024-2034

9.1.1. Musculoskeletal

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Brain

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Cancer

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Neuropathy

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Pain Management Devices Market, By End User 

10.1. Pain Management Devices Market, by End User, 2024-2034

10.1.1. Physiotherapy Centers

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Hospitals and Clinics

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Pain Management Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Forecast, by End User (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End User (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End User (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End User (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End User (2021-2034)

Chapter 12. Company Profiles

12.1. Nevro Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. LivaNova

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. SPR Therapeutics

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Boston Scientific Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Abbott

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. DJO Global LLC

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Medtronic

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Omron Healthcare Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Smiths Medical

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Melsungen AG

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client